Results for "consumer data right"
431-440 of 521 results for 'consumer data right'
NSW Draft Energy Policy Framework: key changes to consider
The NSW Government is seeking feedback on its long-awaited Draft Energy Policy Framework, which is intended to replace the existing NSW Wind Energy Guideline. The Framework is an important development in the NSW renewable energy sector. ...
No more 'two-stepping' around manner of manufacture?
Australia’s approach to patenting computer‑implemented inventions has just shifted decisively. In Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2025] FCAFC 131, the Full F ...
IP strategies to capitalise on hydrogen projects
Hydrogen is swiftly gaining traction as an attractive proposition in the renewable energy sector due to advancements in technology. That said, investment in hydrogen technology and projects requires strategic management of intellectual property (IP) risks and opportunities. Putting in place good IP governance at the outset will help avoid project setbacks and build a strong platform for future investment and innovation. ...
National Electricity and Gas rules update: October 2020
In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of October, as well as take a closer look at the Data Strategy proposed by the ESB. ...
New ASIC guidance on how superannuation and managed funds can avoid 'greenwashing'
Greenwashing in the promotion of managed investment and superannuation funds is one of ASIC's current corporate governance priorities as it continues to 'monitor the market … looking for misleading claims about ESG and sustainability'. ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
What the recent surge in IP filings means for your business
In this Insight, we summarise the Report findings and highlight key factors for businesses to consider in managing their IP risks and IP opportunities. ...
World first: Australia says ‘yes’ to AI inventors
The decision in Thaler v Commissioner of Patents [2021] FCA 879 is the first judicial determination in the world in favour of AI systems being named as inventors of a patent. The availability of patent protection for AI-generated inventions is a vexed and controversial issue. ...
Vietnam's new Land Law offers project developers more certainty and new complexities
Extensive changes to the Land Law are set to align the legal framework to acquire land more closely with practical realities, particularly for energy and infrastructure project developers. ...